---

Cancer Treatment Information

Cancer Treatment Information > Clinical Trials > Conferences

Conferences

OncoLink at ASTRO 2009

Adjuvant Radiotherapy Improves Regional (Lymph Node Field) Control in Melanoma Patients after Lymphadenectomy: Results of an Intergroup Randomized Trial (TROG 02.01/ANZMTG 01.02)

Five-year Analysis of Treatment Efficacy and Cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in Patients Treated with Accelerated Partial Breast Irradiation (APBI)

Outcomes following Accelerated Partial Breast Irradiation in Patients with ASTRO Consensus Statement Cautionary Features

Phase III Study of Prophylactic Cranial Irradiation vs. Observation in Patients with Stage III Non–small-cell Lung Cancer: Neurocognitive and Quality of Life Analysis of RTOG 0214

Survival Impact of Prophylactic Cranial Irradiation in Limited-stage Small-cell Lung Cancer

OncoLink at PTCOG 2009

Carbon Ion Therapy for Patients with Pancreas Cancer

OncoLink at ASCO 2009

Efficacy of BSI-201, a poly (ADP-ribose) polymerase-1 (PARP1) inhibitor, in combination with gemcitabine/carboplatin (G/C) in patients with metastatic triple-negative breast cancer (TNBC): Results of a randomized phase II trial

Ginger for chemotherapy-related nausea in cancer patients: A URCC CCOP randomized, double-blind, placebo-controlled clinical trial of 644 cancer patients

Idiotype vaccine therapy (BiovaxID) in follicular lymphoma in first complete remission: Phase III clinical trial results

A phase III trial comparing mFOLFOX6 to mFOLFOX6 plus bevacizumab in stage II or III carcinoma of the colon: Results of NSABP Protocol C-08

Randomized, double-blind, placebo-controlled phase II study of carboplatin and paclitaxel with or without vorinostat, a histone deacetylase inhibitor (HDAC), for first-line therapy of advanced non-small cell lung cancer (NCI 7863)

Routine Preventive Care and Cancer Surveillance in Long-Term Survivors (LTS) of Colorectal Cancer: Results from NSABP Protocol LTS-01

Surveillance and screening for new neoplasms in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS)

2009 Gastrointestinal Cancers Symposium

Cetuximab-based neoadjuvant chemoradiation and surgical resection in patients with locally advanced esophageal and gastric cancer

Effect of extended preoperative chemotherapy on pathologic response and pathologic livery insufficiency after hepatic resection of colorectal liver metastases

Use of endoscopic ultrasonography in screening patients at high-risk for pancreatic cancer

OncoLink at ASTRO 2008

Acupuncture for the Treatment of Vasomotor Symptoms in Breast Cancer Patients Receiving Hormone Suppression Treatment

Comparative Analysis of Second Malignancy Risk in Patients Treated with Proton Therapy versus Conventional Photon Therapy

The Impact of Short Course Pre-Operative Radiotherapy on Patients’ Quality of Life: Data from the MRC CR07/ NCIC CO16 Randomised Clinical Trial in Patients with Rectal Cancer

Long-term Results of a Randomized Trial of Accelerated Hypofractionated Whole Breast Irradiation Following Breast Conserving Surgery in Women with Node-Negative Breast Cancer

Outcomes using IMRT Tumor-bed Boost for Medulloblastoma

OncoLink at PTCOG 2008

15 years of Proton Radiosurgery Experience at the Ithemba Labs, Long Term Results for AVM’s, Meningiomas, and Acoustic Neuromas

Clinical Trials in Particle Therapy

Comparison of Proton and Photon Radiation Treatment Plans for the Adjuvant Treatment of Pancreatic Cancer Including Comprehensive Nodal Radiation

Panel Discussion: Randomized Trials vs. Prospective Registry

Use of Particle Therapy in Treatment of Sarcomas

OncoLink at PTCOG 2007

Acute Esophageal Reactions from Proton Beam Therapy and Concurrent Chemotherapy for Non-Small Cell Lung Cancer: Reduction in Incidence and Severity Despite Higher Doses

OncoLink at ASCO 2008

ACOSG ZO531: Report on a Multicenter, Phase II Trial for Adjuvant Therapy of Resected Pancreatic Cancer Using Cisplatin, 5-FU, and Alpha-Interferon

Adjuvant ovarian suppression combined with tamoxifen or anastrazole, alone or in combination with zoledronic acid, in premenopausal women with endocrine-responsive, stage I and II breast cancer: First efficacy results from ABCSG

Cancer-related fatigue interferes with activities of daily living among 753 patiens receiving chemotherapy: A URCC CCOP study

Effect of intravenous calcium and magnesium (IV CaMg) on oxaliplatin-induced sensory neurotoxicity (sNT) in adjuvant colon cancer: Results of the phase III placebo-controlled, double blind NCCTG trial N04C7

Effect of paroxetine on depression and insomnia in 547 fatigued cancer patients undergoing chemotherapy

Electronic self-report assessment for cancer (ESRA-C): Results of a randomized clinical trial

Evaluation of chromosome 17 (Chr-17) polysomy in Her2 FISH-negative metastatic breast cancer (MBC) patients enrolled in a randomized phase III study of paclitaxel and lapatinib

KRAS Status and Efficacy in the First –Line Treatment of Patients with Metastatic Colorectal Cancer (mCRC) Treated with FOLFIRI with or without Cetuximab: The Crystal Experience

A Phase III trial comparing FULV to FULV + oxaliplatin in stage II or III carcinoma of the colon: Survival results of NSABP Protocol C-07

Randomised, double-blind, placebo controlled, phase III study of bevacizumab (BV) with docetaxel (D) or docetaxel with placebo (PL) as first line therapy for patients with locally recurrent or metastatic breast cancer (mBC): AVADO

Randomized Phase III Study of Capecitabine, Oxaliplatin, and Bevacizumab with or without Cetuximab in Advanced Colorectal Cancer (ACC), the CAIRO2 Study of the Dutch Colorectal Cancer Group (DCCG)

A randomized phase III trial of four cisplatin (CIS) containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: A Gynecologic Oncology Group (GOG) study

SO124: A Randomized Phase III Trial Comparing Irinotecan/Cisplatin (IP) with Etoposide/Cisplatin (EP) in Patients (pts) with Previously Untreated Extensive Stage Small Cell Lung Cancer (E-SCLC)

OncoLink at ASTRO 2007

Can Adjuvant Neck Dissection be Deferred in Locally Advanced Head and Neck Cancer Patients wtih Complete Response to Definitive Chemoradiotherapy?

Inhibition of mTOR Radiosensitizes Soft Tissue Sarcoma and Tumor Vascualture

The Integrin-TGFbeta Axis: Inhibition of Integrin Alpha v Beta6 Prevents Radiation-Induced Lung Fibrosis.

A Phase III Trial to Compare Standard Versus Accelerated Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas (RTOG 0129): Report of Compliance and Toxicity

A Small Molecular Inhibitor of TGFß Protects Against the Development of Radiation Induced Lung Injury

OncoLink at the 2007 San Francisco Radiation Oncology Conference

Traditional Chinese Medicine in the Management of Treatment Related Pneumonitis-Rational and Evidence

OncoLink at ASCO 2007

Adjuvant external beam radiotherapy (EBRT) in the treatment of endometrial cancer: Results of the randomised MRC ASTEC and NCIC CTG EN.5 trial

The cognitive effects of modafinil in breast cancer survivors: A randomized clinical trial

Cumulative False-Positives (FP) in the Prostate, Lung, Colorectal, Ovarian (PLCO) Cancer Screening Trial

Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases

Phase III trial of cisplatin (P) plus etoposide (E) plus concurrent chest radiation (XRT) with or without consolidation docetaxel (D) in patients with inoperable stage III non-small cell lung cancer (NSCLC): HOG LUN 01-24/USO-023

Phase III trial of cisplatin (P) plus etoposide (E) plus concurrent chest radiation (XRT) with or without consolidation docetaxel (D) in patients with inoperable stage III non-small cell lung cancer (NSCLC): HOG LUN 01-24/USO-023.

Phase III Trial of Ixabepilone plus Capecitabine Compared to Capecitabine Alone in Patients with Metastatic Breast Cancer (MBC) Previously Treated or Resistant to an Anthracycline and Resistant to Taxanes.

Randomized phase III trial of sorafenib versus placebo in patients with advanced hepatocellular carcinoma (HCC)

A randomized, controlled, double-blind phase III study (AVOREN) of bevacizumab/interferon-a2a vs. placebo/interferon-a2a as first-line therapy in metastatic renal cell carcinoma

Randomized, double-blind multicentre phase III study of bevacizumab in combination with cisplatin and gemcitabine in chemotherapy-naïve patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC)

Ratio of metastatic to examined lymph nodes is a powerful predictor of overall survival in rectal cancer

OncoLink at ISH 2007

Detection of BCR-ABL Point Mutations in Patients with Chronic Myeloid Leukemia (CML) Resistant to Imatinib and Prognosis

OncoLink at the San Antonio Breast Cancer Symposium 2006

Combined Clinical Trial Results Of A HER2/Neu (E75) Vaccine For Prevention Of Recurrence In High-Risk Breast Cancer Patients

OncoLink Professor On-Call: Lawrence Solin, MD provides exclusive expert review and insights from the recent San Antonio Breast Cancer Symposia for OncoLink

OncoLink at ASTRO 2006

The 2006 Worldwide Overview of the Effects of Local Treatments for Early Breast Cancer On Long-term Outcome? "Meta-analysis of the Randomized Trials of Radiotherapy After Mastectomy With Axillary Clearance"

Adjuvant Chemoradiation for Adenocarcinoma of the Pancreas: The Johns Hopkins Experience

Biochemical Recurrence and Late Toxicity Following External Beam Radiotherapy Combined With Permanent Source Prostate Brachytherapy: Analysis of RTOG 0019

Intergroup RTOG 9811: Phase III Comparison of Chemoradiation With 5-FU and Mitomycin Vs. 5-FU and Cisplatin for Anal Canal Carcinoma: Impact on Disease-Free, Overall and Colostomy-Free Survival

A Phase III Intergroup Trial (RTOG 97-04) of Adjuvant Pre- and Post-chemoradiation (CRT) 5-FU vs. Gemcitabine (G) for Resected Pancreatic Adenocarcionma

OncoLink at ASCO 2006

Adjuvant chemotherapy in elderly patients: An analysis of National Cancer Institute of Canada Clinical Trials Group and Intergroup BR.10

Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): Update of Cancer and Leukemia Group B (CALGB) protocol 9633.

The impact of FLIPI on outcome of frontline treatment with single-agent I-131 tositumomab for follicular lymphoma (FL)

The impact of initial treatment of advanced stage indolent lymphoma on the risk of transformation.

Lung Adjuvant Cisplatin Evaluation (LACE): A pooled analysis of five randomized clinical trials including 4,584 patients.

Patient Summary: Lung Adjuvant Cisplatin Evaluation (LACE): A pooled analysis of five randomized clinical trials including 4,584 patients

Patient Summary: Motexafin gadolinium (MGd) combined with prompt whole brain radiation therapy (RT) prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Results of a phase III trial

Randomized phase III trial of capecitabine/cisplatin (XP) vs. continuous infusion of 5FU/cisplatin (FP) as first line therapy in patients (pts) with advanced gastric cancer (AGC): Efficacy and safety results.

RTOG 9704 a phase III study of adjuvant pre and post chemoradiation (CRT) 5-FU vs. gemcitabine (G) for resected pancreatic adenocarcinoma

OncoLink at the Chemotherapy Foundation Symposium 2005

Adjuvant Therapy for Rectal Cancer

Experience with ABI-007 (Abraxane) in Head and Neck Cancers

Ixabepilone in Breast Cancer

Motexafin Gadolinium (MGd): Targeting Oxidative Stress Pathways for the Treatment of Non-Hodgkin's Lymphoma

Panitumumab, A Fully-Human IgG2 Antibody Treatment for Colorectal Cancer

OncoLink at ASTRO 2005

ASTRO Patient Summary: A Phase I Clinical Trial Assessing Temozolamide and Tamoxifen with Concomitant Radiotherapy for the Treatment of High-Grade Gliomas

Objective Versus Subjective Assessment of Single Photon Emission Computed Tomography (SPECT) Cardiac Perfusion Scans to Assess for Radiation Therapy (RT) Induced Cardiac Injury

A Phase I Clinical Trial Assessing Temozolamide and Tamoxifen with Concomitant Radiotherapy for the Treatment of High-Grade Gliomas

The Prognostic Value of the Epidermal Growth Factor Receptor in Locally Advanced Rectal Cancer (LARC) Patients Treated with Preoperative Chemo-radiation

Radiation Therapy (RT) as a Chemosensitizer of Gemcitabine (G) in Patients with Metastatic/Unresectable Tumors of the Gastrointestinal (GI) Tract - a Phase I/II Study Exploring a New Treatment Paradigm

Use of Postoperative Radiotherapy (PORT) for Resectable Non-Small Cell Lung Cancer (NSCLC).

OncoLink at WCLC 2005

ISEL: A Phase III survival study comparing gefitinib (IRESSA) plus best supportive care (BSC) with placebo plus BSC, in patients with advanced non-small cell lung cancer (NSCLC) who had received one or two prior chemotherapy regimens

Lung cancer patient utilization of an Internet based cancer clinical trials matching system

Percutaneous radiofrequency ablation of primary NSCLC

OncoLink at ASCO 2005

The David A. Karnofsky Memorial Award and Lecture

Dietary fat reduction in postmenopausal women with primary breast cancer: Phase III Women's Intervention Nutrition Study (WINS)

Erlotinib plus gemcitabine compared to gemcitabine alone in patients with advanced pancreatic cancer.  A phase III trial of the National Cancer Institute of Cancada Clinical Trials Group (NCIC-CTG)

Long-term survival results of a randomized multinational phase 3 trial of dacarbazine (DTIC) with or without Bcl-2 antisense (oblimersen sodium) in patients with advanced malignant melanoma

A phase I study of erlotinib and bevacizumab for recurrent or metastatic squamous cell carcinoma of the head and neck (HNC).

OncoLink at ASTRO 2004

Breast Cancer Patients Attitudes Towards Clinical Trials in the Radiation Oncology Clinic Versus Those Searching for Trial Information on the Internet

The Influence of Race on the Attitudes of Radiation Oncology Patients Towards Clinical Trial Enrollment

OncoLink at ASCO 2004

Comparison of outcomes of phase II trials (P2Ts) and subsequent randomized control trials (RCTs) using identical therapeutic regimens

Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM).  Conclusive results of a radomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials Group.

Does the addition of chemotherapy (CT) to preoperative radiotherapy (preopRT) increase the pathological response in patients with resected rectal cancer: Report of the 22921 EORTC phase III trial.

Eliminating the Suffering and Death from Cancer: A Cancer Center Director's Experience

Expanded access program (EAP) to investigational drugs

Gefitinib (ZD1839) therapy for advanced bronchioloalveolar lung cancer (BAC): Southwest Oncology Group (SWOG) Study S0126

HMG CoA reductase inhibitors and the risk of colorectal cancer

June 6 Highlights

Monitoring circulating tumor cell (CTC) levels to predict rapid progression in metastatic breast cancer (MBC): a prospective, multi-institutional trial

OncoLink at ASCO 2004 CME for June 5, 2004

OncoLink at ASCO 2004 CME for June 6, 2004

OncoLink at ASCO 2004 CME for June 7, 2004

Phase II trial of bevacizumab and erlotinib in patients with metastatic renal carcinoma (RCC)

Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB non-small cell lung cancer: Report of Cancer and Leukemia Group B (CALGB) Protocol 9633

Randomized intergroup trial of first line treatment for patients </= 60 years with diffuse large B-cell non-Hodgkin's lymphoma (DLBCL) with a CHOP-like regimen with or without the anti-CD20 antibody rituximab- early stopping after the first interim analysis

Report card for accelerated FDA approval oncology drugs (1995-2003): is it time for a make-up test?

Risk-adapted management of stage I seminoma: the second Spanish Germ Cell Cancer Group (GG) study

What we learned on June 5, 2004

What we learned on Monday June 7, 2004

OncoLink at the Chemotherapy Foundation Symposium 2003

Clinical Updates and New Approaches: Hematologic Malignancies and GI Cancers

Clinical Updates and New Approaches: Ovarian Cancer, Head and Neck Cancer, and Adjuvant Therapy for Breast Cancer

Clinical Updates and New Approaches: Prostate Cancer, Lung Cancer, and Clinical Support & Outcomes

Erythropoietic Agents: Recent Clinical Data

Optimized Schedule of Weekly Paclitaxel Alone and With Carboplatin: Elderly Advanced NSCLC Patients

Vaccines for Breast Cancer: Real Challenge or Reality?

OncoLink at ASTRO 2003

Adjuvant versus Neoadjuvant Combined Modality Treatment for Locally Advanced Rectal Cancer: First Results of the German Rectal Cancer Study (CAO/ARO/AIO-94)

Amifostine As Mucosal Protectant in Patients with Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Receiving Intensive Chemotherapy and Thoracic Radiotherapy (RT): Results of the Radiation Therapy Oncology Group (RTOG) 98-01 Study

CTRT 99/97 A Randomized Trial of Simultaneous Paclitaxel and Radiotherapy vs. Radiotherapy Alone Following Induction Chemotherapy in Stage III Inoperable NSCLC

A Randomized Trial Comparing Two Fractionation Schedules for Patients with Localized Prostate Cancer

OncoLink at ASCO 2003

Can biochemical failure (ASTRO definition) be used as a surrogate endpoint for prostate cancer survival in phase III localized prostate cancer clinical trials? Analysis of RTOG protocol 92-02

The impact of concurrent versus sequential tamoxifen and radiation therapy in breast cancer patients undergoing breast conservation therapy.

Natural history of progression of patients with biochemical (PSA) relapse following radical prostatectomy: Update

Neoadjuvant chemotherapy for primary high grade extremity soft tissue sarcoma: A matched case control study

P53, EGFR, and PTEN as markers of diagnosis and prognosis in patients with anaplastic glioma enrolled in NCCTG clinical trials

A randomized study of concomitant radiotherapy with cisplatin or carboplatin versus radiotherapy alone in patients with locally advanced non-nasopharygeal head and neck cancer. A Hellenic Cooperative Oncology Group (HeCOG) phase III study

OncoLink at ASH 2002

Bexxar Radioimmunotherapy Produces a Substantial Number of Durable Complete Responses in Patients with Multiply Relapsed or Refractory Low Grade or Transformed Low Grade Non-Hodgkin's Lymphoma

Consolidation of AML Therapy with Autograft and Allograft Procedures Does not Negate the Poor Prognostic Impact of FLT-3 Internal Tandem Duplications: Results for UK MRC AML 10 and 12 Trials.

Effects of 40,000 IU Bi-Weekly (BIW) Induction Dose of Epoetin Alfa Followed by 40,000 IU Once Weekly (QW) in Low-Risk Myelodysplastic Syndrome (MDS) Patients.

Oral Fludarabine phosphate as first-line treatment of chronic lymphocytic leukemia

Zevalin Radioimmunotherapy is Not Associated with an Increased Incidence of Secondary Myelodysplastic Syndrome (MDS) or Acute Myelogenous Leukemia (AML)

OncoLink at ASTRO 2002

Accelerated Partial Breast Irradiation Via Interstitial Brachytherapy as the Sole Radiation Modality for Treatment of Early-Stage Breast Cancer

Axillary Lymph Node Dose With Modern Tangential Breast Radiation

Changing Trends in the National Practice for External Beam Radiotherapy for Clinically Localized Prostate Cancer: The 1999 Patterns of Care Survey for Prostate Cancer

Conflicts of Interest In Science

Eighteen-Year Results in the Treatment of Early-Stage Breast Cancer With Breast Conservation Versus Mastectomy

Long-Term Complication Risk After Very High Dose Thoracic Radiotherapy

Patterns of Failure for Resected Advanced Head & Neck Cancer Treated by Concurrent Chemotherapy and Radiation Therapy: An Analysis of RTOG 9501/Intergroup Phase III Trial

Radiotherapy (RT) Patterns of Care Study (PCS) in Lung Carcinoma

Screening Mammography Is Associated with Earlier Stage Disease and Greater Eligibility for Breast Conservation in Women Aged 40 and Older with Breast Cancer

Significant Relationship Between Hemoglobin (Hb) Levels and Quality of Life (QOL) During Chemoradiation: Findings From an Incremental Analysis of a 442-Patient, Prospective, Community-Based Epoetin Alfa Study

OncoLink at ASCO 2002

Inhibition of Epidermal Growth Factor/HER2 Receptor Signaling Using ZD1839

Issues in the Access of Promising New Cancer Agents

Lymphatic Mapping And Sentinel Lymph Node Sampling In Breast Cancer: A Meta-Analysis

A Phase II Trial Of Pemetrexed In Malignant Pleural Mesothelioma (MPM) Patients: Clinical Outcome, Role Of Vitamin Station, Respiratory Symptoms Upplemenand Lung Function

A randomized phase III trial of preoperative chemoradiation followed by surgery (CR-S) versus surgery alone (S) for localized resectable cancer of the esophagus

Updated results of a randomized controlled trial of neoadjuvant cisplatin (C), methotrexate (M) and vinblastine (V) chemotherapy for muscle-invasive bladder cancer

Weekly Erythropoietin For Patients With Chemotherapy Induced Anemia: A Randomized, Placebo-Controlled Trial In The North Central Cancer Treatment Group

OncoLink at ASH 2001

High incidence of Thalidomide-Associated Deep Vein Thrombosis (DVT) and Pulmonary Emboli (PE) when Chemotherapy is also administered

OncoLink at ASTRO 2001

The Impact of Anemia on PSA Outcome following Radiation and Androgen Suppression Therapy in Patients with High-Risk Prostate Cancer

Internet Utilization by Radiation Oncology Patients

Mature Survival Results with Preoperative Cisplatin, Protracted Infusion 5-FU, and 45 GY Radiotherapy for Esophageal Cancer

Molecular Markers of Patient Outcome in Prostate Cancer Treated with Radiotherapy: Ki-67, Bcl-2, Bax, and Bcl-x

OncoLink at ASCO 2001

American Cancer Society Award Winner Sidney Winawer, MD, Discusses the Progress and Promise of Colorectal Cancer Screening

Bone Mineral Density In Premenopausal Patients In A Randomized Trial Of Adjuvant Endocrine Therapy (ZIPP-TRIAL)

Clinical pharmacology of paclitaxel in relation of patient age: CALGB 9762

Effect Of An SSRI Antidepressant On Fatigue And Depression In Seven Hundred Thirty-Eight Cancer Patients Treated With Chemotherapy: A URCC CCOP Study

Effect Of Raloxifene After Tamoxifen On Breast And Endometrial Cancer Growth

Evaluation Of The Safety And Efficacy Of An Oral Molecularly-Targeted Therapy, STI-571, In Patients (PTS) With Unresectable Or Metastatic Gastrointestinal Stromal Tumors (GISTS) Expressing C-KIT (CD117)

Incidence And Prognostic Impact Of Amenorrhea During Adjuvant Therapy In High Risk Premenopausal Breast Cancer Patients: Analysis Of A National Cancer Institute Of Canada Clinical Trials Group (NCIC CTG) Phase III Study

Informed consent to cancer clinical trials

Maximizing Local Control And Organ Preservation In Advanced Squamous Cell Head And Neck Cancer (SCHNC) With Hyperfractionated Radiation (HRT) And Concurrent Chemotherapy

Nutrition and Cancer: An Update

Opening Address: NCI Director Dr. Richard Klausner Welcomes ASCO Members

Recombinant Human Keratinocyte Growth Factor (RHUKGF) Prevents Chemotherapy-Induced Mucositis In Patients With Advanced Colorectal Cancer: A Randomized Phase II Trial

Satisfaction and anxiety are improved with the use of an easy-to-read informed consent document: a randomized multi-group study

Surgical Resection with or without pre-operative chemotherapy in oesophageal cancer: an updated analysis of a randomized controlled trial conducted by the UK Medical Research Council Upper GI Tract Cancer Group

OncoLink at ASCO 2000

A clinical trial comparing concurrent Cisplatin and radiation therapy versus radiation alone for locally advanced Squamous Cell Carcinoma of the cervix carried out by the National Cancer Institute of Canada Clinical Trials Group

Clinical Trial Costs Are Similar To and May be Less Than Standard Care and Inpatient (INPT) Charges at an Academic Medical Center (AMC) are Similar to Major, Minor and Non-Teaching Hospitals

Forum on Clinical Trials and Public Perception Focuses on the Role of the Media

A Multi-Center Study of the Costs of Enrolling Cancer Patients on Phase II Clinical Trials

Venlafaxine Alleviates Hot Flashes: An NCCTG Trial

OncoLink at ASTRO 2000

Final Keynote Address Highlights the Uncertainties Surrounding Prostate Cancer Screening and Treatment

Panel Presentation Examines the Use of Unconventional Medical Therapies by Cancer Patients

Randomized treatment of brain metastasis with gamma knife radiosurgery, whole brain radiotherapy or both

Senator Kennedy (D-MA) Tells Radiation Oncologists He Will Continue to Support Physicians' and Patients' Best Interests
He Also Urges Their Involvement in Debates Over the Pain Relief Promotion Act

OncoLink at ASCO 1999

ASCO Surveys Demonstrate Problems with Clinical Trials System

Carboplatin/Paclitaxel Preferable to Cisplatin/Paclitaxel in Optimal Stage III Epithelial Ovarian Cancer

Cyclophosphamide/Cisplatin Possibly Preferable Preferable to 32P in Treament of Early High-Risk Ovarian Cancer

First Independent Assessment of Breast Cancer Risk Reduction Drugs Supports a Role for Tamoxifen Therapy

Soy Remedy Not Effective for Hot Flashes with Breast Cancer

OncoLink at ASTRO 1999

Chemoprevention for Head and Neck Cancer

Giulio D'Angio, M.D. Received Gold Medal Award November 2nd from the American Society for Therapeutic Radiation Oncology

Gold Medal Award Presentations Kick Off Day 4 at ASTRO Conference

Panel Discusses the Rapidly Evolving Standards of Care for Cervix Cancer

Prelimimary results of a randomized dose-escalation study comparing 70 Gy to 78 Gy for the treatment of prostate cancer

OncoLink at ASCO 1998

Older Breast Cancer Patients can Tolerate Adjuvant Therapy with Doxorubicin and Cyclophosphamide

Study Finds that Elderly are Severely Underrepresented in Clinical Trials

Tamoxifen Reduces Breast Cancer Incidence by 45% in Women at High Risk of Developing the Disease

OncoLink at ASCO 1996

A Clinical Trial Of Antigen-Pulsed Dendritic Cells (DC) In The Treatment Of Patients With B-Cell Lymphoma

The Internet for Oncologists: Hunting for Genes on the World Wide Web

John H. Glick, MD Gives Presidential Address

Optimal Timing of Breast Cancer Surgery Within Menstrual Cycle

Phase I/II Trial Results Of 131-I-Anti-B1 (Anti-CD20) Non-Myeloablative Radioimmunotherapy For Refractory B-Cell Lymphoma